Compelo Medical Devices - Latest industry news and analysis is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More
Close
Dismiss

NIMS collaborates with NMRC for Exer-Rest

Non-Invasive Monitoring Systems (NIMS) has entered into a cooperative research and development agreement (CRADA) with the Naval Medical Research Center (NMRC), to evaluate the benefit of Exer-Rest for patients with traumatic brain injury (TBI).

The Exer-Rest is FDA listed Class I Exempt and non-invasive medical device which applies Whole Body Periodic Acceleration (WBPA) from head-to-foot to improve circulation and provide pain relief.

NIMS founder and CEO Marvin Sackner said that whole Body Periodic Acceleration therapy increases endogenous nitric oxide in the circulation, to help TBI patients by increasing brain blood flow, reducing inflammation and oxidative stress thereby relieving neuropsychiatric symptoms and improving vitality.

The Exer-Rest is available in the US, Canada and other major international markets and also approved in the UK, European Union, Health Canada and Mexico as an aid to increasing circulation and for increasing joint mobility.